S
Susan M. Webb
Researcher at Autonomous University of Barcelona
Publications - 303
Citations - 8784
Susan M. Webb is an academic researcher from Autonomous University of Barcelona. The author has contributed to research in topics: Acromegaly & Quality of life. The author has an hindex of 48, co-authored 281 publications receiving 7646 citations. Previous affiliations of Susan M. Webb include Carlos III Health Institute & Hospital de Sant Pau.
Papers
More filters
MonographDOI
Proceedings of the Integrated Ocean Drilling Program Volume 338, NanTroSEIZE Stage 3: NanTroSEIZE Plate Boundary Deep Riser 2
Michael Strasser,Brandon Dugan,Kyuichi Kanagawa,Gregory F. Moore,Sean Toczko,Lena Maeda,Yukari Kido,Kyaw Moe,Y. Sanada,L. Esteban,Olivier Fabbri,J. Geersen,Sven Hammerschmidt,Hiroki Hayashi,K. Heirman,Andre Hüpers,Maria José Jurado,Koji Kameo,Toshiya Kanamatsu,Hiroko Kitajima,H. Masuda,Kitty L. Milliken,Ravi Mishra,Isao Motoyama,K. Olcott,K. Oohashi,K. T. Pickering,S. G. Ramirez,Harunur Rashid,Derek E. Sawyer,Anja M. Schleicher,Y. Shan,R. M. Skarbek,I. Song,T. Takeshita,T. Toki,Joanne Tudge,Susan M. Webb,D. J. Wilson,Hao Wu,A. and Yamaguchi +40 more
Journal ArticleDOI
Telomere length analysis in Cushing's syndrome
Anna Aulinas,María José Ramirez,María-José Barahona,Elena Valassi,Eugenia Resmini,Eugenia Mato,Alicia Santos,Iris Crespo,Olga Bell,Jordi Surrallés,Susan M. Webb +10 more
TL;DR: Preliminary results suggest that hypercortisolism might negatively impact telomere maintenance and contribute to premature aging and morbidity in Cushing's syndrome patients.
Journal ArticleDOI
Health-related Quality of Life in Primary and Secondary Adrenal Insufficiency
Anna Aulinas,Susan M. Webb +1 more
TL;DR: This review focuses on psychological morbidity and impaired quality of life in patients with primary or secondary AI of any origin, including a special section devoted to congenital adrenal hyperplasia.
Journal ArticleDOI
Long-lasting Subclinical Addison's Disease
TL;DR: Autoimmune adrenal disease can have a very long preclinical period even with high concomitant ACTH and specific antibody titers.
Journal ArticleDOI
A polymorphism in the CYP17A1 gene influences the therapeutic response to steroidogenesis inhibitors in Cushing's syndrome.
Elena Valassi,Anna Aulinas,Camilla A M Glad,Camilla A M Glad,Gudmundur Johannsson,Gudmundur Johannsson,Oskar Ragnarsson,Oskar Ragnarsson,Susan M. Webb +8 more
TL;DR: Steroidogenesis inhibitors, such as ketoconazole (KTZ) and metyrapone (MTP), are used to lower hypercortisolism in patients with Cushing's syndrome.